FDA Inspection
Santosh M. Nair, MDSantosh M. Nair, MD – FDA Inspection, Feb 26, 2020
Record Details
This FDA Inspection record concerns Santosh M. Nair, MD, with an inspection on February 26, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Santosh M. Nair, MD
- Inspection Date
- February 26, 2020
- Product Type
- Drugs
View Company Profile
ID · 58de3cd9-7259-4047-b641-e8b9ed1f7d7f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120127
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Santosh M. Nair, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Santosh M. Nair, MD
- FDA Inspection 1218710 - 2023-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.